Mater Hospitals

Featured in: Favicon

nature.com Favicon

springer.com Favicon

biomedcentral.com Favicon

oxfordjournals.org Favicon

thelancet.com Favicon

ejcancer.com Favicon

jofskin.org + 5 more

Articles

Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, r

1 week ago | thelancet.com | Georgina V. Long |Mater Hospitals |James Garrett |Victoria Atkinson

aRonald O Perelman Department of Dermatology, NYU Grossman School of Medicine, NYU Langone Health, New York City, NY, USA bLaura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York City, NY, USA cMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia dRoyal North Shore and Mater Hospitals, Sydney, NSW, Australia eNovartis Pharmaceuticals Corporation, Cambridge, MA, USA fPrincess Alexandra Hospital, Gallipoli Medical Research Foundation, University of...

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →